.Pharmacolibrary.Drugs.ATC.N.N07CA02 .Pharmacolibrary.Drugs.ATC.N.N07CA02| name: | Cinnarizine |
| ATC code: | N07CA02 | route: | oral |
| n-compartments | 1 |
Cinnarizine is a piperazine derivative antihistamine commonly used to treat and prevent motion sickness, vertigo, and balance disorders. It acts as a selective calcium channel blocker and histamine H1 receptor antagonist. Although widely used in many countries, cinnarizine is not approved for use in the United States or some other regions.
Reported pharmacokinetic parameters in healthy adult volunteers after a single oral dose administration.
Paton, DM, & Webster, DR (1985). Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines). Clinical pharmacokinetics 10(6) 477–497. DOI:10.2165/00003088-198510060-00002 PUBMED:https://pubmed.ncbi.nlm.nih.gov/2866055
Ramirez, G, et al., & Boyd, BJ (2021). Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration. Drug delivery and translational research 11(3) 1236–1244. DOI:10.1007/s13346-020-00851-z PUBMED:https://pubmed.ncbi.nlm.nih.gov/32935235
Yan, M, et al., & Zhu, YG (2010). Quantitative determination of pimozide in human plasma by liquid chromatography-mass spectrometry and its application in a bioequivalence study. Journal of pharmaceutical and biomedical analysis 51(5) 1161–1164. DOI:10.1016/j.jpba.2009.11.015 PUBMED:https://pubmed.ncbi.nlm.nih.gov/19969437